Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products
暂无分享,去创建一个
Toshiyuki Miyashita | Masao Yamada | T. Miyashita | K. Tadokoro | Mayu Yamazaki-Inoue | Maki Tachibana | M. Fujishiro | K. Nagao | M. Toyoda | M. Ozaki | M. Ono | N. Miki | M. Yamada | Masashi Toyoda | Keiko Tadokoro | Mayu Yamazaki-Inoue | Maki Tachibana | Mina Fujishiro | Kazuaki Nagao | Miwako Ozaki | Masami Ono | Nobuhiro Miki | Mayu Yamazaki‐Inoue | Kazuaki Nagao
[1] C. Ross,et al. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. , 1996, Brain research. Molecular brain research.
[2] I. Kanazawa,et al. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease , 1998, Neurogenetics.
[3] S. Tsuji,et al. Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. , 1995, American journal of human genetics.
[4] C. Shen,et al. One‐codon alternative splicing of the CpG MTase Dnmt1 transcript in mouse somatic cells , 2000, FEBS letters.
[5] T. Hashikawa,et al. Protein processing and releases of neuregulin‐1 are regulated in an activity‐dependent manner , 2004, Journal of neurochemistry.
[6] Y. Okamura-Oho,et al. Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates , 2001, Cell Death and Differentiation.
[7] C A Ross,et al. Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.
[8] Christine Van Broeckhoven,et al. Pathogenesis of polyglutamine disorders: aggregation revisited. , 2003, Human molecular genetics.
[9] H. Zoghbi,et al. Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.
[10] S. Tsuji,et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch , 1998, Nature Genetics.
[11] K. Tadokoro,et al. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.
[12] S. L. Berger,et al. GAG triplets as splice acceptors of last resort. An unusual form of alternative splicing in prothymosin alpha pre-mRNA. , 1993, Journal of molecular biology.
[13] Y. Okamura-Oho,et al. Expression of extended polyglutamine sequentially activates initiator and effector caspases. , 1999, Biochemical and biophysical research communications.
[14] R. Shamir,et al. How prevalent is functional alternative splicing in the human genome? , 2004, Trends in genetics : TIG.
[15] A. Sano,et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p , 1994, Nature Genetics.
[16] A. J. Lopez,et al. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. , 1998, Annual review of genetics.
[17] G. Condorelli,et al. Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics. , 1994, The Journal of biological chemistry.
[18] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[19] K. Vogan,et al. An alternative splicing event in the Pax-3 paired domain identifies the linker region as a key determinant of paired domain DNA-binding activity , 1996, Molecular and cellular biology.
[20] Y. Okamura-Oho,et al. Dentatorubral Pallidoluysian Atrophy (DRPLA) Protein Is Cleaved by Caspase-3 during Apoptosis* , 1997, The Journal of Biological Chemistry.
[21] M. Hayden,et al. Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity* , 2003, The Journal of Biological Chemistry.
[22] Y. Okamura-Oho,et al. Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate. , 1999, Human molecular genetics.
[23] N. Miki,et al. Regulation of pituitary growth hormone-releasing factor (GRF) receptor gene expression by GRF. , 1996, Biochemical and Biophysical Research Communications - BBRC.
[24] E. Hell,et al. Human Obese Gene Expression: Alternative Splicing of mRNA and Relation to Adipose Tissue Localization , 1997, Obesity surgery.
[25] Y. Okamura-Oho,et al. Genomic structure and alternative splicing of the insulin receptor tyrosine kinase substrate of 53-kDa protein , 2003, Journal of Human Genetics.
[26] J. Valcárcel,et al. Splicing Regulation at the Second Catalytic Step by Sex-lethal Involves 3′ Splice Site Recognition by SPF45 , 2002, Cell.
[27] W. Johnson,et al. Diffusion mechanisms in metallic supercooled liquids and glasses , 1999, Nature.
[28] Christopher J. Lee,et al. A genomic view of alternative splicing , 2002, Nature Genetics.
[29] Y. Okamura-Oho,et al. Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine. , 2000, Human molecular genetics.
[30] Michael R. Green,et al. Functional recognition of the 3′ splice site AG by the splicing factor U2AF35 , 1999, Nature.
[31] K. Tadokoro,et al. PCR detection of 9 polymorphisms in the WT1 gene. , 1993, Human molecular genetics.
[32] Thangavel Alphonse Thanaraj,et al. ASD: the Alternative Splicing Database , 2004, Nucleic Acids Res..
[33] International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome , 2004 .
[34] R. Reed,et al. An Upstream AG Determines Whether a Downstream AG Is Selected during Catalytic Step II of Splicing , 2001, Molecular and Cellular Biology.
[35] A. Hackam,et al. Cleavage of Atrophin-1 at Caspase Site Aspartic Acid 109 Modulates Cytotoxicity* , 1999, The Journal of Biological Chemistry.
[36] C. Ross,et al. Cloning and expression of the rat atrophin-I (DRPLA disease gene) homologue , 1995, Neurobiology of Disease.
[37] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.
[38] Y. Okamura-Oho,et al. Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase. , 2003, Human molecular genetics.
[39] Y. Okamura-Oho,et al. Intracellular aggregate formation of dentatorubral-pallidoluysian atrophy (DRPLA) protein with the extended polyglutamine. , 1998, Biochemical and biophysical research communications.
[40] Rolf Backofen,et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.
[41] Tim Hubbard. Finishing the euchromatic sequence of the human genome , 2004 .